CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY (Unaudited) (Tables)

12 Months Ended

Jul. 31, 2023

Condensed Financial Information Disclosure [Abstract]

Schedule of balance sheets

	July 31,
	2023
		(Unaudited)
ASSETS
Cash	$	66,553
Prepaid expense		1,750
Receivable from subsidiaries		29,487
Investment in subsidiaries		95,889
Total Assets	$	193,679
LIABILITIES
Accounts payable and accrued liabilities	$	241,579
Due to related parties		223,041
Total Liabilities		464,620
Stockholders’ equity
Series A Preferred stock, $0.0001 par value; 80,000 shares authorized; 80,000 shares issued and outstanding as of July 31, 2023		8
Undesignated preferred stock, $0.0001 par value; 20,000,000 shares authorized; no shares issued and outstanding		–
Common stock, $0.0001 par value, 100,000,000 shares authorized; 5,903,481 shares issued and outstanding as of July 31, 2023		590
Additional paid-in capital		4,982
Accumulated deficit		(276,521	)
Total stockholders’ equity		(270,941	)
Total Liabilities and Stockholders’ Equity	$	193,679

Schedule of statements of operations

	From March 3, 2023 to July 31, 2023
		(Unaudited)
EXPENSES:
General and administrative	$	207,297
Loss from investment in subsidiaries		133,913
Total expenses		341,210
Net Loss	$	(341,210	)

Schedule of statements of cash flows

	From March 3, 2023 to July 31, 2023
		(Unaudited)
Cash flows from operating activities:
Net loss	$	(341,210	)
Adjustments to reconcile net loss to net cash used in operating activities:
Share of loss from investment in subsidiaries		133,913
Change in operating assets and liabilities:
Prepaid expense		1,500
Accounts payable and accrued liabilities		117,651
Net cash (used in) operating activities		(88,146	)
Cash flows from financing activities:
Repayment of working capital advance from related party		(30,000	)
Operating expenses directly paid for subsidiary		(29,487	)
Common Stock issued to Roshing employees and affiliates for services rendered		210,000
Net cash provided by financing activities		150,513
Net increase in cash and cash equivalents		62,367
Cash and cash equivalents at March 3, 2023		4,186
Cash and cash equivalents at July 31, 2023	$	66,553